Skip to main content

G8 backs HIV vaccine plan

A global program styled on the Human Genome Project gets the nod from world leaders

Written byRobert Walgate
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

MONTREUX—The world's leading industrial powers have given their support to a US proposal for an international alliance to accelerate HIV vaccine research, US President George Bush announced yesterday (June 10) at the conclusion of the G8 meeting in Sea Island, Georgia.

The idea is to create "a virtual consortium" based on a joint strategic plan, Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, told a briefing yesterday. "When other nations… decide they want to align their own resources or put new resources into vaccine development, there will be a strategic plan framework with which they can synergize," he said.

Scientists gathered here in Switzerland at a vaccine development conference warmly welcomed the support for the new "Global HIV Vaccine Enterprise," a concept developed by Richard Klausner and colleagues at the Bill and Melinda Gates Foundation.

José Esparza from the Gates Foundation said: "The G8 statement ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo